News

On August 15, 2025, Greater Bay Area International Clinical Trial Institute (GBAICTI) welcomed the "'Hong Kong Express' GBA Biomedical Enterprise Delegation Tour" at a seminar hosted at Invest Hong Kong. The delegation, organized by the Shenzhen Qianhai Hong Kong Chamber of Commerce, included over 30 representatives from prominent GBA biomedical companies, aiming to build a bridge for cross-border cooperation.

Alongside representatives from InvestHK and the Hong Kong-Shenzhen Innovation and Technology Park (HSITP), GBAICTI introduced the key advantages of Hong Kong's biomedical ecosystem, focusing on its policy support and world-class clinical trial resources. The presentation sparked a lively discussion on topics like conducting international multi-center clinical trials and cross-border research transformation.